Skip to content

Study · Ex vivo tissue · rat · 1988

6 results

Vasoactive intestinal peptide receptors in rat spleen and brain: a shared communication network.

Wiedermann CJ, Sertl K, Zipser B, Hill JM, Pert CB

Peptides1 Jan 1988Cited by 13 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study6

6 results from studies that gave the peptide. No result from this study comes from people.

  1. 01LabEx vivo tissueMechanism

    In rat spleen, 125I-VIP bound to red pulp and most abundantly to the periarteriolar lymphoid sheath of the white pulp.

    In plain wordsIn lab tests on rat spleen, labelled VIP attached mostly to the white pulp region that holds T cells.

    Outcome
    Not applicable125I-VIP binding sites in spleen
    Study

    ratn: not reported in source

    Spleen and brain tissue sections
    Outcome group
    Receptor activity and mechanism · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    In spleen, specific binding of 125I-VIP occurs on red pulp and, most abundantly, on the periarteriolar lymphoid sheath (PALS) of white pulp.
    1 context sentence
    Summary · context
    The binding sites for [125I]-vasoactive intestinal polypeptide (125I-VIP) in rat spleen and brain were localized using autoradiography.
  2. 02LabEx vivo tissueMechanism

    High affinity VIP receptors are present in rat spleen, with competition studies typical of VIP receptors elsewhere.

    In plain wordsIn lab tests, rat spleen had high affinity VIP receptors like those found in other tissues.

    Outcome
    Not applicableHigh affinity VIP receptors in spleen
    Study

    ratn: not reported in source

    Spleen and brain tissue sections
    Outcome group
    Receptor activity and mechanism · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    High affinity VIP receptors are present in rat spleen, and competition studies reflect structure-activity relationship typical of VIP receptors elsewhere.
    1 context sentence
    Summary · context
    The binding sites for [125I]-vasoactive intestinal polypeptide (125I-VIP) in rat spleen and brain were localized using autoradiography.
  3. 03LabEx vivo tissueActivity measurement

    In rat spleen sections, unlabelled VIP competed for 125I-VIP binding to both red pulp and white pulp.

    In plain wordsIn lab tests on rat spleen, plain VIP competed with labelled VIP for binding in both red and white pulp.

    Outcome
    Not applicableCompetition by unlabelled VIP for binding in spleen
    Study

    ratn: not reported in source

    Spleen and brain tissue sections
    Outcome group
    Receptor activity and mechanism · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Unlabeled VIP competes for binding to both red pulp and white pulp
    1 context sentence
    Summary · context
    The binding sites for [125I]-vasoactive intestinal polypeptide (125I-VIP) in rat spleen and brain were localized using autoradiography.
  4. 04LabEx vivo tissueMechanism

    In rat brain, VIP receptors are widely distributed, with the highest densities in sensory areas including the olfactory bulb, thalamic nuclei, cranial nuclei and area postrema.

    In plain wordsIn lab tests on rat brain, VIP receptors were widespread, and most dense in sensory areas.

    Outcome
    Not applicableVIP receptor distribution in brain
    Study

    ratn: not reported in source

    Spleen and brain tissue sections
    Outcome group
    Receptor activity and mechanism · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    In the brain, VIP receptors are widely distributed with the highest densities occurring in "sensory" areas. Receptors are abundant in the olfactory bulb, thalamic nuclei, several cranial nuclei and the area postrema.
    1 context sentence
    Summary · context
    The binding sites for [125I]-vasoactive intestinal polypeptide (125I-VIP) in rat spleen and brain were localized using autoradiography.
  5. 05LabEx vivo tissueMechanism

    High levels of 125I-VIP binding occurred on the inner walls of blood vessels in rat brain and spleen.

    In plain wordsIn lab tests on rat tissue, labelled VIP attached strongly to the inner walls of blood vessels in brain and spleen.

    Outcome
    Not applicable125I-VIP binding on blood vessel walls
    Study

    ratn: not reported in source

    Spleen and brain tissue sections
    Outcome group
    Receptor activity and mechanism · Cardiovascular
    Studied dose
    Dose not stated

    Source sentences

    Summary
    High levels of 125I-VIP binding occurred on inner walls of blood vessels of the brain and spleen.
    1 context sentence
    Summary · context
    The binding sites for [125I]-vasoactive intestinal polypeptide (125I-VIP) in rat spleen and brain were localized using autoradiography.
  6. 06LabEx vivo tissueActivity measurement

    In rat spleen sections, secretin displaced 125I-VIP binding to the periarteriolar lymphoid sheath more potently than to red pulp.

    In plain wordsIn lab tests on rat spleen, secretin pushed labelled VIP off the white pulp region more strongly than off the red pulp.

    Outcome
    Not applicableSecretin displacement of 125I-VIP binding in spleen
    Study

    ratn: not reported in source

    Spleen and brain tissue sections
    Outcome group
    Receptor activity and mechanism · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    whereas secretin displaces binding to PALS more potently than to red pulp.
    1 context sentence
    Summary · context
    The binding sites for [125I]-vasoactive intestinal polypeptide (125I-VIP) in rat spleen and brain were localized using autoradiography.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 12:58 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 12:41 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.